This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
GOAT ANTI HUMAN CD154
catalog :
AHP1029
quantity :
0.1 mg
price :
477 USD
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
reactivity :
human
application :
western blot, ELISA
product information
EntityType :
Polyclonal Antibody
EntityCategory :
Antibodies
ProductCode :
AHP1029
Description :
GOAT ANTI HUMAN CD154
Specificity :
CD154
TargetSpecies :
Human
Host :
Goat
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
P*,WB,E
ApplicationTypes :
Western Blotting,ELISA,Immunohistology - Paraffin
CrossReactivities :
Yeast
Quantity :
0.1 mg
QuantityValue :
0.1
QuantityType :
mg
GOAccessions :
GO:0005125,GO:0005887,GO:0045190,GO:0042100,GO:0032735,GO:0030168,GO:0007159,GO:0005625,GO:0006916,GO:0006954,GO:0005174,GO:0005615,GO:0005164
GOTerms :
autocrine activity,paracrine activity,TNF receptor binding,tumor necrosis factor,tumor necrosis factor receptor ligand,intercellular space,soluble,apoptosis inhibitor activity,leukocyte adhesion,leukocyte cell adhesion,blood coagulation, platelet activation,activation of interleukin-12 production,positive regulation of IL-12 production,stimulation of interleukin-12 production,up regulation of interleukin-12 production,up-regulation of interleukin-12 production,upregulation of interleukin-12 production,B lymphocyte proliferation,B-cell proliferation,B-lymphocyte proliferation,GO:0042114,class switch recombination,class switching,isotype switch recombination
UniprotAccessions :
P29965
Gene :
CD40LG
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=959
PublishedSynonyms :
CD40 LIGAND
EntityFormats :
Biotin,Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0mg/ml after reconstitution
ProductForm :
Purified IgG - lyophilized
PriceGBP :
341
PriceEUR :
477
PriceUSD :
477 USD
PriceCHF :
519.93
PriceSEK :
5013
PriceNOK :
5109
PriceDKK :
3558
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments